Update: Merck recovers from Vioxx (CNN Money)
What we said In "Merck Is on the Mend" (Feb. 5), we recommended a second look at the pharma giant, which was recovering from the low it reached in 2004 amid the Vioxx debacle. We mentioned that Merck was winning approvals for a host of new drugs, including cervical-cancer vaccine Gardasil. We cited Bear Stearns analyst John Boris's year-end price target of $53.

Corporate America looks to Washington to settle question of what s natural food (AG Weekly)
WASHINGTON It s a fight that has the nation s largest chicken producers squabbling, Big Sugar and Big Corn skirmishing and Sara Lee mixing it up with Farmer John.

GeoPharma, Inc. Receives FDA Approval to Manufacture and Distribute Carprofen (The San Francisco Examiner)
LARGO, Fla. ( Map ) - LARGO, Fla., Nov. 12 /PRNewswire-FirstCall/ -- GeoPharma, Inc. (Nasdaq: GORX ) (the "Company") GeoPharma, Inc. announced today it has received an approval from the FDA to begin producing Carprofen.